Peter Dreger

26.3k citations
604 papers · 20.5k · 6 hit papers · h-index 74

Impact in

  • Hematology top 0.05%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
  • Genetics top 0.1%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Hematopoietic Stem Cell Transplantation 249
    • Acute Myeloid Leukemia Research 21
    • Multiple Myeloma Research and Treatments 16
    • Chronic Lymphocytic Leukemia Research 125
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 10

Peter Dreger

578 papers receiving 20k citations

Peter Dreger's Hit Papers

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma 2025 · 28 citations
280+3+6Years since publication100200300400

Peers

Peter Dreger
Comparison fields: 5 of 135
  • Hematology 8.5k
  • Genetics 4k
  • Pathology and Forensic Medicine 3.5k
  • Oncology 3.1k
  • Immunology 1.1k
Replace Pellegrino Musto with:
Pellegrino Musto Italy
Steven Michael Devine United States
Jiri Mayer Czechia
Norbert Schmitz Germany
Parameswaran Hari United States
Jean-Yves Y. Cahn France
Luca Arcaini Italy
Andrew Grigg Australia
Sherry A. Pierce United States
André Tichelli Switzerland
Peter Dreger relative to Pellegrino Musto Italy Pellegrino Musto's profile →
Citations per field
00.5×1.5×1.9×
Pellegrino Musto · 1×
Citations per year

Countries citing papers authored by Peter Dreger

Since Specialization
Citations

This map shows the geographic impact of Peter Dreger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Dreger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Dreger more than expected).

Fields of papers citing papers by Peter Dreger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Dreger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Dreger. The network helps show where Peter Dreger may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Dreger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Dreger Line = papers co-authored together Peter Dreger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 604 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1996501
2
Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
Hit paper breakdown →
2020409
3 1995394
4
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
Hit paper breakdown →
2016326
5 2009319
6 2006281
7 2015268
8
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
Hit paper breakdown →
2019264
9 2013258
10 1994252
11 2010229
12 2010229
13 2012227
14 2009224
15 2009219
16 2017203
17 2012200
18 2012198
19
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Hit paper breakdown →
2023197
20 1995196

About Peter Dreger

Peter Dreger is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Immunology, having authored 604 papers that have together received 20.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (249 papers), Chronic Lymphocytic Leukemia Research (125 papers), Lymphoma Diagnosis and Treatment (121 papers), CAR-T cell therapy research (62 papers), Acute Myeloid Leukemia Research (21 papers), Multiple Myeloma Research and Treatments (16 papers), Viral-associated cancers and disorders (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers). The work is most often cited by research in Hematology (8.5k citations), Genetics (4k citations), Pathology and Forensic Medicine (3.5k citations), Oncology (3.1k citations) and Immunology (1.1k citations). Peter Dreger has collaborated with scholars based in Germany, France and United Kingdom. Frequent co-authors include Norbert Schmitz, Thomas Luft, Carsten Müller‐Tidow, Anthony Dick Ho, Anna Sureda-Balarí, Michael W. Schmitt, Torsten Haferlach, Meinolf Suttorp, Axel Benner and Nicolaus Martin Kröger. Their work appears in journals such as Blood, Bone Marrow Transplantation, Leukemia, Transplantation and Cellular Therapy and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact